Abstract:The combination of bright, tunable semiconductor quantum dots (QDs) emitting in the shortwave infrared or second near infrared window (SWIR/NIR-II, 1000 – 1600 nm) and InGaAs camera-equipped preclinical imagers opens the door to non-invasive, multiplexed, deep tissue imaging in live mice. While imaging in the NIR-I is like imaging through fog due to highly scattering tissue, imaging in the SWIR/NIR-II is more like imaging through pond water, enabling deeper imaging with much improved resolution. We synthesized multiple PbS/CdS core/shell QDs with emission wavelengths spanning 1000-1600 nm. These particles have been encapsulated in lipid-PEG micelles and up to three colors (so far) dosed into nude mice for imaging on a Photon Etc IR VIVO imager equipped with a hyperspectral Bragg grating and 6 bandpass filters, enabling demixing of the discrete colors. We have obtained exceptionally clear images of lymphatic drainage and the vasculature system, including visualization of lymphatic valve opening in videos. Interestingly, following intravascular injection, the liver and spleen are very visible and distinct, enabling the non-invasive visualization of a key nanomedicine drug delivery parameter (i.e., are the nanoparticles accumulating in the liver or the spleen?). Image processing investigations are expanding our ability to demix colors as well as to determine the average depth of the contrast agent, based on the wavelength-dependent attenuation of the photoluminescence based on water absorption. In addition to the photophysical advantages of using QDs for NIR-II, elemental analysis of blood and tissue samples enables quantitative biodistribution and pharmacokinetic studies. Ongoing work involves the application of this imaging approach to assess the impact nanomaterial surface properties and route of delivery on their pharmacokinetics and the use of deep tissue paired agent imaging for non-invasive “optical biopsy” of orthotopic tumors. Current data are already visually stunning, and ongoing imaging highlights new opportunities for research with every experiment! Figure 1

Direct water-phase synthesis of lead sulfide quantum dots encapsulated by β-lactoglobulin for in vivo second near infrared window imaging with reduced toxicity.

Facile Synthesis of Β-Lactoglobulin Capped Ag2S Quantum Dots for in Vivo Imaging in the Second Near-Infrared Biological Window.

Highly Fluorescent Ribonuclease-A-Encapsulated Lead Sulfide Quantum Dots for Ultrasensitive Fluorescence in Vivo Imaging in the Second Near-Infrared Window

Recycled Synthesis of Whey-Protein-Capped Lead Sulfide Quantum Dots As the Second Near-Infrared Reporter for Bioimaging Application

Alloyed Geometric Structure Strategy Enables High-Quality Water-Soluble Quantum Dots for Ultrasensitive Fluorescence Immunoassay

'Green'-Synthesized Near-Infrared PbS Quantum Dots with Silica-Peg Dual-Layer Coating: Ultrastable and Biocompatible Optical Probes for in Vivo Animal Imaging.

High Quantum Yield Water‐Dispersed Near‐Infrared In(Zn)As–In(Zn)P–GaP–ZnS Quantum Dots with Robust Stability for Bioimaging

One-pot Synthesis of Water-Dispersible Ag2S Quantum Dots with Bright Fluorescent Emission in the Second Near-Infrared Window.

Bright quantum dots emitting at ∼1,600 nm in the NIR-IIb window for deep tissue fluorescence imaging

Water-Soluble Lipophilic Near-Infrared Region II Fluorophores for High-Brightness Lipid Layer and Lipid Droplets Imaging Applications

Stable Monodisperse Pb<sub>1-<i>x</i></sub>Cd<sub><i>x</i></sub>S Quantum Dots for NIR-II Bioimaging by Aqueous Coprecipitation of Bimetallic Clusters

In situ aqueous synthesis of genetically engineered polypeptide-capped Ag2S quantum dots for second near-infrared fluorescence/photoacoustic imaging and photothermal therapy

Quaternary Ammonium Salt Based NIR‐II Probes for In Vivo Imaging

Aqueous Synthesis of PEGylated Ag2S Quantum Dots and Their in Vivo Tumor Targeting Behavior.

(Invited) Designing Quantum Dots for Multiplexed Deep-Tissue Imaging in the NIR-II

Near-infrared emissive lanthanide hybridized carbon quantum dots for bioimaging applications.

Development of Non-Cadmium I-III-VI Quantum Dots and their Surface Modification for Biomedical Applications

Facile One-Pot Synthesis of Monodispersed NIR-II Emissive Silver Sulfide Quantum Dots

Aqueous, Non-Polymer-Based Perovskite Quantum Dots for Bioimaging: Conserving Fluorescence and Long-Term Stability via Simple and Robust Synthesis

Real-Time in Vivo Detection and Monitoring of Bacterial Infection Based on NIR-II Imaging

Acid-Resistant Near-Infrared II Ag 2 Se Quantum Dots for Gastrointestinal Imaging